Indications and uses
relieves occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours
relieves occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours
Take only by mouth. Doses may be taken as a single daily dose or in divided doses. adults and children 12 years and over take 1 - 3 softgels daily children 2 to under 12 years of age take 1 softgel daily children under 2 years ask a doctor
each softgel contains: sodium 6 mg very low sodium store at 20-25°C (68-77°F)
Docusate sodium 100 mg
Stool softener laxative
taking any other drug. Take this product two or more hours before or after other drugs. Laxatives may affect how other drugs work.
do not exceed the maximum recommended daily dosage in a 24-hour period
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
adults and children 12 years and over | take 1 - 3 softgels daily |
children 2 to under 12 years of age | take 1 softgel daily |
children under 2 years | ask a doctor |
D&C red no. 33, edible ink, FD&C blue no. 1, FD&C red no. 40, FD&C yellow no. 6, gelatin, glycerin, polyethylene glycol, purified water, sorbitol sorbitan solution, titanium dioxide
1-800-719-9260
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67296-1835-2 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-7fde-d83d-e063-dadaa90ab31f | Perrigo Docusate Sodium 100 mg Drug Facts |
| 67296-1835-6 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-7fde-d83d-e063-dadaa90ab31f | Perrigo Docusate Sodium 100 mg Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67296-1835-2 | Docusate Sodium | 20 in 1 BOTTLE | CAPSULE, LIQUID FILLED | 20 | 1 | |
| 67296-1835-6 | Docusate Sodium | 60 in 1 BOTTLE | CAPSULE, LIQUID FILLED | 60 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67296-1835 | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [REDPHARM DRUG, INC.] | 1 | 2 package rows | 20230216_f4236180-d2bc-3a1e-e053-2a95a90a84b9.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 45802-486-78 | EA - Each | 45802-486 | efff330d-ac0a-4908-8da3-b9e544bfb324 | 1 | 2012-07-24 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 67296-1835 | 67296-1835-2, 67296-1835-6 |
| 45802-486 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| D&C RED NO. 33 | 9DBA0SBB0L | IACT |
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| GELATIN, UNSPECIFIED | 2G86QN327L | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| WATER | 059QF0KO0R | IACT |
| SORBITAN | 6O92ICV9RU | IACT |
| SORBITOL | 506T60A25R | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| DOCUSATE SODIUM | F05Q2T2JA0 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Docusate Sodium | DOCUSATE SODIUM | Padagis Israel Pharmaceuticals Ltd | bce3b245-ec47-4e62-9cad-bb12d0812c18 | 2024-08-15 | Warnings | 45802-486 |
| f4236180-d2bd-3a1e-e053-2a95a90a84b9 | f4236180-d2bc-3a1e-e053-2a95a90a84b9 | 2023-02-07 | Warnings | f4236180-d2bd-3a1e-e053-2a95a90a84b9 f4236180-d2bc-3a1e-e053-2a95a90a84b9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.